Stock Market Reviews

Read and share opinions on ADXN (Addex Therapeutics Ltd) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

Latest News

• Addex Increases Issued Share Capital to Create Treasury Shares
  Oct 29, 2025
• Addex Therapeutics Ltd (ADXN) Q2 2025 Earnings Call Highlights: Strategic Advances Amid ...
  Oct 1, 2025
• Addex Therapeutics to Report 2025 Half-year and Second Quarter Financial Results on September 30, 2025 and Host Conference Call on October 1, 2025
  Sep 26, 2025
• Addex Appoints Bank of New York Mellon as Depositary Bank
  Sep 23, 2025
• Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders
  Jun 30, 2025
• Addex Shareholders Approve All Resolutions at Annual General Meeting
  Jun 25, 2025
• Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025
  Jun 18, 2025
• Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models
  Jun 6, 2025
• Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference
  Jun 5, 2025
• Addex Convenes Annual General Meeting 2025
  Jun 3, 2025
• Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies
  May 12, 2025
• Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery
  Apr 30, 2025
• Addex Therapeutics to Release Full-Year 2024 Financial Results and Host Conference Call on April 25, 2025
  Apr 24, 2025
• Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149
  Apr 17, 2025
• Addex to Present at the 2025 Swiss Equities Baader Conference
  Jan 8, 2025